Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at lenalidomide (Revlimid) for mantle cell lymphoma when other treatments are no longer working, or it has come back after treatment.
Recruitment start: 30 April 2009
Recruitment end: 7 March 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Simon Rule
Celgene Corporation
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 13 December 2017
CRUK internal database number: 5958
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
